Resistance to systemic immune checkpoint inhibition in the peritoneal niche
10.1136/jitc-2022-004749
June 21, 2022
Commentary/Editorials
Section Edited by Christian M. Capitini, MD
Perspectives on imaging and immunotherapy: a review series
10.1136/jitc-2022-005006
June 16, 2022
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research
10.1136/jitc-2021-004397
June 16, 2022
Celebrating a decade of the Journal for ImmunoTherapy of Cancer
10.1136/jitc-2022-005207
May 20, 2022
Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment
10.1136/jitc-2021-002944
April 5, 2022
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study
10.1136/jitc-2021-004157
March 9, 2022
Immunostimulatory effects of radioimmunotherapy
10.1136/jitc-2021-004403
February 21, 2022
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment
10.1136/jitc-2021-003540
January 31, 2022
Mac Cheever (1944–2021): a tribute to a life of achievement and service
10.1136/jitc-2021-004433
January 12, 2022
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study
10.1136/jitc-2021-003323
November 19, 2021